Newsroom

APRIL 26, 2021 Glytec, a Waltham, MA-based provider of insulin management software across the continuum of care, raised $21m in financing. The financing included: $9m debt financing from SVB, and $12m equity investment led by Savitr Capital and other private investors. The company intends to use the funds to invest in research and development around patient safety, provider workflows and...

APRIL 2021 Derek Bagley A proof-of-concept study recently published in Diabetes Care shows how inpatient diabetes technology is advancing and can provide meaningful improvements in care today and in a post-pandemic world. The research team, led by Francisco J. Pasquel, MD, MPH, assistant professor of medicine in the Division of Endocrinology at Emory University in Atlanta, write that...

APRIL 12, 2021 The Medical Design Excellence Awards competition is the medical technology industry's premier awards program. Since 1998, the MDEAs have recognized achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility. Each year, a panel of jurors comprised of designers, engineers, and clinicians awards bronze, silver, gold, and...

APRIL 2021 Derek Bagley Recently, Metro Health – University of Michigan Health, an affiliate of University of Michigan Health, announced that it reduced incidence of hypoglycemia by more than 54% and experienced a 40% decline in hyperglycemia since implementing personalized insulin dosing software. Glytec is marketing the software as the eGlycemic Management System® (eGMS). Extensive research...

MARCH 30 2021 Sean Whooley Glytec announced today that it introduced the latest version of its eGlycemic Management System (eGMS) for managing insulin. Waltham, Mass.-based Glytec’s eGMS is centered around the FDA-cleared Glucommander algorithm, which leverages real-time and historical data to recommend insulin dosing by learning each patient’s insulin sensitivity and anticipating future...

MARCH 31 2021 Amy Reyes Patients with diabetic ketoacidosis and a COVID-19 diagnosis died at increasingly higher rates than diabetic ketoacidosis patients without COVID-19, shows an analysis recently published in JAMA Network Open. Published online March 10 as a research letter, physicians led by Francisco J. Pasquel, MD, MPH, of Emory University School of Medicine, Atlanta, conducted an...

MARCH 23 2021 Medically reviewed by Michelle L. Griffith, MD — Written by Ashley Zlatopolsky Taking care of yourself is an important part of managing type 2 diabetes. It often involves making changes to your diet and lifestyle, developing a workout plan, taking your medications, and monitoring your blood sugar level throughout the day. While managing diabetes can feel overwhelming at first, a...

MARCH 10 2021 Kristen Monaco COVID-19 appeared to increase risk of mortality in people hospitalized with diabetic ketoacidosis (DKA), researchers reported. In a comparison of hospitalized DKA patients from February to September 2020, 30% of those who also had COVID-19 died in the hospital, as compared with 5% of those who didn't have COVID-19, reported Francisco Pasquel, MD, MPH, of Emory...

MARCH 10 2021 Miriam Tucker The clinical course and prognosis of individuals hospitalized with diabetic ketoacidosis (DKA) are considerably worse among those who have COVID-19, new data show. In-hospital death was sixfold greater among patients with DKA who had COVID-19 compared with those who did not, and acute kidney injury was three times more common. "These findings are worrisome and...

DECEMBER 2020 Ling Cui, Pamela R. Schroeder and Paul A. Sack Simplified systems were initially developed using this construct to help adjust insulin infusions, but more complex software has since been developed to account for a variety of clinical inpatient scenarios. FDA-approved inpatient electronic glycemic management systems include Glucommander (Glytec), EndoTool System (Monarch Medical...